Schonfeld Strategic Advisors »

Applied Therapeutics shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Applied Therapeutics (APLT) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Applied Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Applied Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Applied Therapeutics by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.6M 492k 3.35
2023-09-30 $1.1M 457k 2.49
2022-03-31 $65k 31k 2.13

More positions owned by Schonfeld Strategic Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
FedEx Corporation (FDX)
Microsoft Corporation (MSFT)
Ishares Msci Brazil Etf Call Option (EWZ)
Ishares Tr U.s. Real Es Etf (IYR)
Mastercard Incorporated Cl A (MA)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Verizon Communications (VZ)
Spdr Ser Tr S&p Biotech (XBI)
Micron Technology (MU)
Johnson Ctls Intl SHS (JCI)

View all positions for Schonfeld Strategic Advisors

Top funds holding Applied Therapeutics

Alyeska Investment Group
Franklin Resources
VR Adviser
Knoll Capital Management
Propel Bio Management
Perceptive Advisors
Vanguard Group
Simplify Asset Management
Henderson Group
Logos Global Management
AIGH Capital Management
Opaleye Management
Millennium Management
Schonfeld Strategic Advisors
Point72 Asset Management

View all funds holding Applied Therapeutics